Center for biologics evaluation and research (cber)pathogen reduction technologies (PRT) research COR: michael fischer
Ended Awarded Last action
- Contract number
- 75F40121F80453
- Awardee
-
The Mitre Corporation UEI DMHDNDCPWUD1 Part of The Mitre Corporation
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $4,726,928
Award facts
- Contract value 100% obligated
- $4,726,928.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Silver Spring, MD 20993, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $253,648 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $4,473,280 |
About this award
This is a cost-plus-fixed-fee delivery order for $4,726,928.00 awarded by the Food and Drug Administration (FDA) to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers. The contract is for research and technical support related to pathogen reduction technologies (PRT) for the FDA's Center for Biologics Evaluation and Research (CBER). The contract has no set-aside designation. The Mitre Corporation has extensive experience supporting federal agencies across a range of initiatives, including national security, healthcare, and other areas through prime and subcontractor roles. This specific delivery order is part of a larger indefinite delivery/indefinite quantity (IDIQ) contract vehicle held by Mitre to provide services to the FDA.
Quick answers
Who was awarded contract 75F40121F80453?
75F40121F80453 was awarded to The Mitre Corporation by Food and Drug Administration (Department of Health and Human Services) on September 29, 2021.
How much is contract 75F40121F80453 worth?
The government has obligated $4,726,928 on 75F40121F80453.
Is contract 75F40121F80453 an order under another contract?
Yes. 75F40121F80453 is a delivery order under 75FCMC18D0047, an indefinite delivery contract.
Was contract 75F40121F80453 competed?
The extent of competition for 75F40121F80453 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award